Literature DB >> 14622179

Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice.

Francina Langa1, Xavier Codony, Victoria Tovar, Alfonso Lavado, Estela Giménez, Patricia Cozar, Marta Cantero, Albert Dordal, Enric Hernández, Raquel Pérez, Xavier Monroy, Daniel Zamanillo, Xavier Guitart, Lluís Montoliu.   

Abstract

Sigma (sigma) sites are a type of nonopiate receptor whose role has been associated with several behaviours, including anxiety, depression, analgesia, learning processes and psychosis. Although there are several known sigma receptor types, only the type I receptor (sigma 1) has been cloned. To uncover the in vivo relevance of sigma-receptors, we have generated knockout mice for sigma 1. Despite the broad expression pattern found for the sigma 1-gene, homozygous mutant mice are viable, fertile and do not display any overt phenotype, compared with their wild-type litter-mates, in mixed genetic backgrounds. However, a significant decrease in the hypermotility response has been measured in knockout mice upon challenge with (+)SKF-10 047, in agreement with the involvement of sigma 1-receptors in the induction of psychostimulant actions. The activity of sigma 2-receptors seems to be unaffected in sigma 1-mutant mice. These knockout mice could contribute to better understand the in vivo role of sigma-receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622179     DOI: 10.1046/j.1460-9568.2003.02950.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  76 in total

Review 1.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

2.  Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N'-dimethyltryptamine forming enzyme, indole-N-methyl transferase.

Authors:  T A Mavlyutov; M L Epstein; P Liu; Y I Verbny; L Ziskind-Conhaim; A E Ruoho
Journal:  Neuroscience       Date:  2012-01-04       Impact factor: 3.590

3.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

4.  Neuroprotective effects of high affinity Σ1 receptor selective compounds.

Authors:  Robert R Luedtke; Evelyn Perez; Shao-Hua Yang; Ran Liu; Suwanna Vangveravong; Zhude Tu; Robert H Mach; James W Simpkins
Journal:  Brain Res       Date:  2011-12-31       Impact factor: 3.252

5.  Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.

Authors:  Chelsy R Eddings; Nicolas Arbez; Sergey Akimov; Michal Geva; Michael R Hayden; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2019-05-17       Impact factor: 5.996

6.  Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor.

Authors:  Arindam Pal; Uyen B Chu; Subramaniam Ramachandran; David Grawoig; Lian-Wang Guo; Abdol R Hajipour; Arnold E Ruoho
Journal:  J Biol Chem       Date:  2008-05-07       Impact factor: 5.157

7.  The sigma receptor: evolution of the concept in neuropsychopharmacology.

Authors:  T Hayashi; Tp Su
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

8.  Characterization of pulmonary sigma receptors by radioligand binding.

Authors:  John R Lever; Tyler P Litton; Emily A Fergason-Cantrell
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

9.  Sigma receptor ligand, (+)-pentazocine, suppresses inflammatory responses of retinal microglia.

Authors:  Jing Zhao; Yonju Ha; Gregory I Liou; Graydon B Gonsalvez; Sylvia B Smith; Kathryn E Bollinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

10.  Lack of sigma-1 receptor exacerbates ALS progression in mice.

Authors:  T A Mavlyutov; M L Epstein; Y I Verbny; M S Huerta; I Zaitoun; L Ziskind-Conhaim; A E Ruoho
Journal:  Neuroscience       Date:  2013-02-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.